AwardJun 25, 2026, 08:32 AM
Microbot Medical Wins Innovative Start-Up Award for LIBERTY System
AI Summary
Microbot Medical Inc. announced it has won the Innovative Start-Up Award from Surgical Robotics Technology for its LIBERTY Endovascular Robotic System. This award recognizes companies with outstanding technological and commercial progress through groundbreaking technologies. The LIBERTY system, which is FDA-cleared and remotely operated, is being adopted by leading academic centers across several states, further validating its impact on robotic-assisted endovascular care.
Key Highlights
- Microbot Medical Inc. won the Innovative Start-Up Award from Surgical Robotics Technology.
- The award recognizes the LIBERTY Endovascular Robotic System.
- LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- The system is currently used at leading academic centers in NY, PA, FL, GA, MA, MI, and NC.
- The award validates LIBERTY's growing role in advancing robotic-assisted endovascular care.
Price Impact
More from MBOT